Bharat Rasayan Past Earnings Performance
Past criteria checks 4/6
Bharat Rasayan's earnings have been declining at an average annual rate of -7.6%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been declining at an average rate of 0.3% per year. Bharat Rasayan's return on equity is 14.8%, and it has net margins of 13.7%.
Key information
-7.6%
Earnings growth rate
-7.1%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | -0.3% |
| Return on equity | 14.8% |
| Net Margin | 13.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bharat Rasayan makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 11,526 | 1,577 | 919 | 0 |
| 30 Jun 24 | 10,876 | 1,315 | 892 | 0 |
| 31 Mar 24 | 10,446 | 955 | 869 | 0 |
| 31 Dec 23 | 10,409 | 586 | 767 | 0 |
| 30 Sep 23 | 11,172 | 771 | 782 | 0 |
| 30 Jun 23 | 11,461 | 940 | 800 | 0 |
| 31 Mar 23 | 12,343 | 1,246 | 888 | 0 |
| 31 Dec 22 | 13,732 | 1,589 | 980 | 0 |
| 30 Sep 22 | 13,994 | 1,706 | 987 | 0 |
| 30 Jun 22 | 13,768 | 1,742 | 989 | 0 |
| 31 Mar 22 | 13,012 | 1,760 | 929 | 0 |
| 31 Dec 21 | 11,262 | 1,582 | 889 | 0 |
| 30 Sep 21 | 10,128 | 1,479 | 846 | 0 |
| 30 Jun 21 | 10,621 | 1,567 | 839 | 0 |
| 31 Mar 21 | 10,920 | 1,639 | 816 | 0 |
| 31 Dec 20 | 10,932 | 1,533 | 762 | 0 |
| 30 Sep 20 | 10,951 | 1,433 | 730 | 0 |
| 30 Jun 20 | 11,423 | 1,626 | 702 | 0 |
| 31 Mar 20 | 12,151 | 1,576 | 710 | 0 |
| 31 Dec 19 | 12,163 | 1,508 | 693 | 0 |
| 30 Sep 19 | 11,819 | 1,471 | 661 | 0 |
| 30 Jun 19 | 11,015 | 1,283 | 615 | 0 |
| 31 Mar 19 | 9,922 | 1,115 | 590 | 0 |
| 31 Dec 18 | 9,134 | 1,176 | 561 | 0 |
| 30 Sep 18 | 9,125 | 1,194 | 561 | 0 |
| 30 Jun 18 | 8,713 | 1,077 | 520 | 0 |
| 31 Mar 18 | 7,953 | 983 | 511 | 0 |
| 31 Dec 17 | 7,344 | 748 | 490 | 0 |
| 30 Sep 17 | 6,731 | 630 | 463 | 0 |
| 30 Jun 17 | 6,229 | 555 | 421 | 0 |
| 31 Mar 17 | 6,207 | 545 | 423 | 0 |
| 31 Dec 16 | 5,920 | 472 | 395 | 0 |
| 30 Sep 16 | 5,576 | 424 | 376 | 0 |
| 30 Jun 16 | 5,076 | 402 | 353 | 0 |
| 31 Mar 16 | 4,555 | 339 | 339 | 0 |
| 31 Dec 15 | 4,517 | 345 | 424 | 7 |
| 30 Sep 15 | 4,479 | 329 | 410 | 7 |
| 30 Jun 15 | 4,359 | 301 | 396 | 7 |
| 31 Mar 15 | 4,388 | 317 | 297 | 0 |
| 31 Dec 14 | 4,313 | 291 | 386 | 6 |
| 30 Sep 14 | 4,275 | 302 | 380 | 6 |
| 30 Jun 14 | 4,044 | 277 | 371 | 6 |
| 31 Mar 14 | 3,614 | 201 | 336 | 6 |
| 31 Dec 13 | 3,209 | 194 | 262 | 0 |
Quality Earnings: 590021 has high quality earnings.
Growing Profit Margin: 590021's current net profit margins (13.7%) are higher than last year (6.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 590021's earnings have declined by 7.6% per year over the past 5 years.
Accelerating Growth: 590021's earnings growth over the past year (104.5%) exceeds its 5-year average (-7.6% per year).
Earnings vs Industry: 590021 earnings growth over the past year (104.5%) exceeded the Chemicals industry 8%.
Return on Equity
High ROE: 590021's Return on Equity (14.8%) is considered low.